Trials / Unknown
UnknownNCT05793216
VestibulOTherapy: Vestibular Impact on Learning
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- VestibulOTherapy · Industry
- Sex
- All
- Age
- 6 Years – 10 Years
- Healthy volunteers
- Not accepted
Summary
Research Question: Will daily engagement in activities tailored to the evidence-based vestibular research result in improved attention and learning outcomes for children ages 6-9 years of age after an 8-week classroom-based intervention?
Detailed description
"Vestibulotherapy" is an emerging frame of reference aiming to help neurotypical children with under-performing vestibular systems develop neural pathways supporting communication and learning. Theory based upon systematic review: Given adequate vestibular activation through targeted activities (in an otherwise under-performing vestibular system), myelination and neuroplasticity propagate along learning pathways leading to greater neural connectivity and efficiency for sequencing, ordinance, attention, memory, body schema, spatial cognition, executive function, and interoception. As a result of prescribed vestibular interventions and gained attributes supporting learning, students will experience increased academic growth and success as outlined by the following model.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | VestibulOTherapy | For this study, the following activity-orientated interventions will occur within the natural learning environments so that generous opportunities exist for neural plasticity and growth. Each student will be engaged in 20-30 minutes/day of intermittent classroom activities, plus 20-30- minutes of daily stability work embedded into classroom routines including stabilizing self on a Hokki stool or t-stool or standing on a balance board during sedentary work, such as circle time or read-a-loud. |
Timeline
- Start date
- 2023-03-07
- Primary completion
- 2023-05-05
- Completion
- 2023-10-25
- First posted
- 2023-03-31
- Last updated
- 2023-03-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05793216. Inclusion in this directory is not an endorsement.